期刊文献+

极化液个体化治疗对创伤后高血糖病人促/抗炎细胞因子的影响 被引量:3

The effects of individual treatment of GIK on the pro-and anti-inflammatory cytokines of patients with Trauma
下载PDF
导出
摘要 目的:探讨极化液个体化治疗对创伤后高血糖病人促/抗炎细胞因子以及多器官功能障碍综合征(MODS)的影响,为极化液辅助治疗创伤后MODS提供实验依据。方法:将我院重症监护室收治的创伤后高血糖病人,随机分为极化液个体化治疗组(G IK组)和基础治疗组(C组)。观察不同治疗组治疗3 d后创伤病人空腹血糖、乳酸、促炎细胞因子(CRP、TNF-α和IL-1β)和抗炎细胞因子(IL-4和IL-10)水平变化以及MODS的发生率和病死率。结果:GIK组治疗3 d后,空腹血糖、乳酸、C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)和白细胞介素-1β(IL-1β)水平均明显低于C组,血IL-4和IL-10水平明显高于C组。GIK组MODS的发生率明显低于C组,MODS病死率虽略有下降,但与C组比无显著差异。结论:极化液个体化治疗创伤后病人可降低促炎细胞因子和升高抗炎细胞因子水平,对控制创伤后病人的高血糖效果明显。 Objective: To study the effects of individual treatment of GIK(Glucose-Insulin-Potassium) on the pro-and antiinflammatory cytokines and the risk of MODS caused by trauma.Methods: The trauma patients with hyperglycemia in ICU of our hospital,were randomly divided to the GIK group and routine group.The levels of the fasting glucose,lactic acid,pro-inflammatory cytokines(CRP,TNFα,IL-1β) and anti-inflammatory cytokines(IL-4,IL-10),the percentage of MODS and the mortality of MODS were observed in the GIK and routine groups.Results: The levels of the glucose,lactic acid,CRP,TNF-α,IL-1β in GIK groups were lower significantly than that in C groups.The levels of IL-4,IL-10 in GIK groups were higher significantly than that in C groups.The percentage of MODS in GIK group was lower significantly than that in C group.Conclusion: The individual treatment of GIK can contribute to the cure and prevention of MODS caused by trauma by reducing pro-inflammatory cytokines increasing anti-inflammatory cytokines,supplying glucose and ameliorating the abnormal glucose metabolism.
出处 《肠外与肠内营养》 CAS 2007年第5期275-278,共4页 Parenteral & Enteral Nutrition
基金 江西省卫生厅资助课题(20052044) 南京军区医药卫生"十一五"重大课题资助(06Z25) 南京军区卫生专业人才培养"122工程"资助项目
关键词 多器官功能障碍综合征 个体化治疗 促炎细胞因子 抗炎细胞因子 Multiple organ dysfunction syndrome Individual treatment Cytokine Anti-inflammatory cytokines
  • 相关文献

参考文献15

二级参考文献68

  • 1王超,张淑文,阴赬宏,王红,王宝恩.近年来北京地区多器官功能障碍综合征流行病学调查[J].中华创伤杂志,2004,20(12):730-733. 被引量:33
  • 2孟宪钧 王平.肝脏在多器官功能衰竭中的作用[J].中华外科杂志,1988,26(1):13-15.
  • 3叶应妩.全国临床检验操作规程[S]:第2版[M].,1996.123.
  • 4Dellinger RP, Carlet JIM, Masur H, et al. Surviving Sepsis Campaign Management Guidelines Committee. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med, 2004, 32:858-873.
  • 5Tsai MH, Peng YS, Lien JM, et al. Multiple organ system failure in critically Ill cirrhotic patients. A comparison of two multiple organ dysfunction/failure scoring systems. Digestion, 2004, 69:190-200.
  • 6Das UN. Insulin and the critically ill. Crit Care, 2002, 6:262-263.
  • 7Hansen TK, Thiel S, Wouters PJ, et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab, 2003,88:1082-1088.
  • 8Yu WK, Li WQ, Li N, et al. Mononuclear histocompatibility leukocyte antigen-DR expression in the early phase of acute pancreatitis. Pancreatology, 2004, 27,4:233-243.
  • 9Tschaikowsky K, Hedwig-Geissing M, Schiele A, et al. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: longitudinal study of mononuclear histocompathtibility leukocyte antigen-DR expression, procalctonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med, 2002,30:1015-1023.
  • 10van den Berghe G, Wouters P, Weekers F,et al. Intensive insulin therapy in critically ill. N Engl J Med, 2001, 345:1359-1367.

共引文献1614

同被引文献31

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部